Instil Bio, Inc. (TIL) Dividend History

Instil Bio, Inc. (TIL) is a biotechnology company focused on developing personalized cell therapies for cancer treatment. The company utilizes its proprietary platform to engineer and produce tumor-infiltrating lymphocyte (TIL) therapies aimed at enhancing the immune response against solid tumors. Headquartered in the United States, Instil aims to improve outcomes for cancer patients through innovative immunotherapy solutions.

3963 Maple Avenue, Dallas, TX, 75219
Phone: (972) 499-3350
Website: https://www.instilbio.com

Dividend History

Instil Bio, Inc. currently does not pay dividends

Company News

  • Over 180 companies are developing 250+ bispecific antibodies targeting complex chronic diseases like cancer and autoimmune disorders, with innovative dual-targeting molecules offering superior therapeutic precision and efficacy.

    GlobeNewswire Inc.
  • Summit Therapeutics' stock price has soared over 600% since the end of 2023 due to positive trial results for its cancer therapy ivonescimab, which could potentially unseat Merck's Keytruda as the top-selling cancer treatment. However, the company is still pre-commercial and its market valuation may be too high at the moment.

    The Motley Fool
    Featured Companies: MRK SMMT
  • Instil Bio (TIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    Zacks Investment Research
  • Upgrades For OPKO Health Inc (NASDAQ:OPK), Barrington Research upgraded the previous rating of Market Perform to Outperform. For the first quarter, OPKO Health had an EPS of $0.02, compared to year-ago quarter EPS of $0.08. The current stock performance of OPKO Health shows a 52-week-high of $2.85 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.72. For The RealReal Inc (NASDAQ:REAL), B of A Securities upgraded the previous rating of Underperform to Neutral. In the first quarter, RealReal showed an EPS of $0.36, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $3.71 and a 52-week-low of $1.00. At the end of the last trading period, RealReal closed at $1.81. For Schneider National Inc (NYSE:SNDR), Susquehanna upgraded the previous rating of Neutral to Positive. For the first quarter, Schneider National had an EPS of $0.55, compared to year-ago quarter EPS of $0.57. The current stock performance of Schneider National shows a 52-week-high of $30.93 and a 52-week-low of $20.27. Moreover, at the end of the last trading period, the closing price was at $28.32. Canaccord Genuity upgraded the previous rating for Intercept Pharmaceuticals Inc (NASDAQ:ICPT) from Hold to Buy. In the first quarter, Intercept Pharma showed an EPS of $0.77, compared to $0.58 from the year-ago quarter. The current stock performance of Intercept Pharma shows a 52-week-high of $21.86 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $10.90. Morgan Stanley upgraded the previous rating for FREYR Battery (NYSE:FREY) from Equal-Weight to Overweight. In the first quarter, FREYR Battery showed an EPS of $0.09, compared to $0.30 from the year-ago quarter. The current stock performance of FREYR Battery shows a 52-week-high of $16.92 and a 52-week-low of $6.20. Moreover, at the end of the last trading period, the closing price was at $7.55. National Bank Financial Inc upgraded the previous rating for Paramount Resources Ltd (OTC:PRMRF) from Outperform to Sector Perform. The current stock performance of Paramount Resources shows a 52-week-high of $26.15 and a 52-week-low of $16.21. Moreover, at the end of the last trading period, the closing price was at $21.70. For Micron Technology Inc (NASDAQ:MU), Piper Sandler upgraded the previous rating of Underweight to Neutral. Micron Technology earned $1.43 in the third quarter, compared to $2.59 in the year-ago quarter. The stock has a 52-week-high of $74.77 and a 52-week-low of $48.43. At the end of the last trading period, Micron Technology closed at $67.07. See all analyst ratings upgrades. Downgrades For Symbotic Inc (NASDAQ:SYM), UBS downgraded the previous rating of Buy to Neutral. In the second quarter, Symbotic showed an EPS of $0.10, compared to $5.61 from the year-ago quarter. The current stock performance of Symbotic shows a 52-week-high of $53.83 and a 52-week-low of $8.75. Moreover, at the end of the last trading period, the closing price was at $41.84. According to Evercore ISI Group, the prior rating for Ashland Inc (NYSE:ASH) was changed from Outperform to In-Line. In the second quarter, Ashland showed an EPS of $1.43, compared to $1.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $114.32 and a 52-week-low of $80.00. Ashland closed at $83.84 at the end of the last trading period. Loop Capital downgraded the previous rating for RH (NYSE:RH) from Buy to Hold. For the first quarter, RH had an EPS of $2.21, compared to year-ago quarter EPS of $6.63. The current stock performance of RH shows a 52-week-high of $351.53 and a 52-week-low of $207.65. Moreover, at the end of the last trading period, the closing price was at $310.44. Loop Capital downgraded the previous rating for ContextLogic Inc (NASDAQ:WISH) from Hold to Sell. ContextLogic earned $3.83 in the first quarter, compared to $1.80 in the year-ago quarter. The stock has a 52-week-high of $57.90 and a 52-week-low of $6.36. At the end of the last trading period, ContextLogic closed at $7.21. For Citizens Financial Group Inc (NYSE:CFG), JP Morgan downgraded the previous rating of Overweight to Neutral. In the first quarter, Citizens Financial Group showed an EPS of $1.10, compared to $1.07 from the year-ago quarter. The current stock performance of Citizens Financial Group shows a 52-week-high of $44.82 and a 52-week-low of $23.37. Moreover, at the end of the last trading period, the closing price was at $25.66. According to Credit Suisse, the prior rating for Pfizer Inc (NYSE:PFE) was changed from Outperform to Neutral. Pfizer earned $1.23 in the first quarter, compared to $1.62 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.93 and a 52-week-low of $36.03. Pfizer closed at $36.29 at the end of the last trading period. For Inter & Co Inc (NASDAQ:INTR), JP Morgan downgraded the previous rating of Overweight to Neutral. The stock has a 52-week-high of $4.63 and a 52-week-low of $1.37. At the end of the last trading period, Inter & Co closed at $3.02. Keybanc downgraded the previous rating for The Walt Disney Co (NYSE:DIS) from Overweight to Sector Weight. For the second quarter, Walt Disney had an EPS of $0.93, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $126.48 and a 52-week-low of $84.08. Walt Disney closed at $88.83 at the ...Full story available on Benzinga.com

    Benzinga
  • Hot penny stocks to watch with news this week. The post 5 Hot Penny Stocks To Watch This Week With Big News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: CNTX KRON OCGN SONN
Page data last updated 07/23/2025 19:15:10 UTC